Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Automated Cell Processing System Market: Global Trends and Forecast to 2035 | 16% CAGR Unlocks Strategic Opportunities in Cell Therapy Manufacturing

globenewswire.com
AZN AstraZeneca is mentioned as a player associated with the automated cell processing system market, indicating potential involvement or interest in this growing sector. BAX Baxter is listed as a company associated with the automated cell processing system market, suggesting potential engagement with this expanding industry. DHR Danaher Corporation is mentioned as the acquirer of Cytiva and Pall, both of which are associated with the automated cell processing system market, indicating strategic expansion in this area. MRK Merck is listed as a company associated with the automated cell processing system market, suggesting potential involvement or interest in this growing sector.

Automated Cell Processing System Market: Global Trends and Forecast to 2035 | 16% CAGR Unlocks Strategic Opportunities in Cell Therapy Manufacturing Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) -- "Automated Cell Processing System Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Cell Therapy Processing Step, Scale of Operation, End User and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering.

The global automated cell processing system market is valued at USD 220 million in the current year and is projected to expand at a CAGR of 16% during the forecast period. Market growth is being driven by the expanding cell and gene therapy pipeline, increasing demand for scalable manufacturing, and wider adoption of automated and closed cell processing systems.

More than 2,000 cell and gene therapy candidates are currently under investigation across oncological disorders, rare diseases, and chronic diseases. Positive results from FDA-approved therapies have strengthened interest in cellular therapies among pharmaceutical companies, biotechnology developers, healthcare providers, and research organizations. However, conventional cell therapy manufacturing remains labor-intensive and time-consuming, contributing to high production costs and batch-to-batch variations. These limitations are increasing demand for advanced, standardized, and time-efficient processing technologies.

Automated and closed cell processing systems can reduce manual intervention, improve throughput, decrease idle time between production runs, and support more consistent manufacturing. Platforms such as GMP-In-A Box demonstrate how automation can help cell therapy developers streamline workflows and manage production costs. These operational benefits are expected to support sustained expansion of the automated cell processing system market.

Market Segmentation

The market sizing and opportunity analysis covers the following segments:

Automated Cell Processing System Market Insights

Competitive Landscape

Equipment developers are integrating advanced capabilities into automated cell processing platforms to strengthen product differentiation and address evolving manufacturing requirements. Competition is influenced by system functionality, supplier capabilities, processing compatibility, scalability, regulatory readiness, support services, and the range of cell types and culture formats supported.

Example players associated with the automated cell processing system market include AstraZeneca, Baxter, Bayer, Cytiva (Acquired by Danaher Corporation), Cellular Therapeutics, Lonza, Merck, Pall (Acquired by Danaher Corporation), Terumo BCT, and ThermoGenesis.

Research Coverage

Key Questions Addressed

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/lr6xez

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.